Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 4
1983 2
1984 1
1986 3
1987 1
1988 7
1990 2
1991 7
1992 5
1993 4
1994 6
1995 3
1996 8
1997 6
1998 5
1999 4
2000 14
2001 18
2002 11
2003 23
2004 34
2005 43
2006 43
2007 44
2008 69
2009 76
2010 92
2011 97
2012 108
2013 109
2014 112
2015 133
2016 105
2017 115
2018 114
2019 112
2020 125
2021 129
2022 118
2023 138
2024 114
2025 114

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,083 results

Results by year

Filters applied: . Clear all
Page 1
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.
Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J, Zhou YF, Fu T, Lin CJ, Dai LJ, Liu CL, Zhao S, Su GH, Hou W, Liu Y, Chen Q, Yang J, Zhang N, Zhang WJ, Liu W, Ge W, Yang WT, You C, Gu Y, Kaklamani V, Bertucci F, Verschraegen C, Daemen A, Shah NM, Wang T, Guo T, Shi L, Perou CM, Zheng Y, Huang W, Shao ZM. Jiang YZ, et al. Among authors: zhang wj. Nat Cancer. 2024 Apr;5(4):673-690. doi: 10.1038/s43018-024-00725-0. Epub 2024 Feb 12. Nat Cancer. 2024. PMID: 38347143
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Liu ZD, Peng LS, Zhang WJ, Sun H, Chen ZY, Wang DH, Peng D, Chen SA, Li SQ, Zhang Z, Tan XY, Yang J, Zhao ZY, Zhang WT, Su J, Li YS, Liao RQ, Dong S, Xu CR, Zhou Q, Yang XN, Wu YL, Zhang ZM, Zhong WZ. Zhang C, et al. Among authors: zhang wj. Cell Rep Med. 2024 Jul 16;5(7):101615. doi: 10.1016/j.xcrm.2024.101615. Epub 2024 Jun 18. Cell Rep Med. 2024. PMID: 38897205 Free PMC article. Clinical Trial.
The X-Age Project to construct a Chinese aging clock.
Li J, Jiang M, Wang Q, Zheng Z, Shen J, Li J, Xiong M, Zheng Y, Lu X, Cai Y, Fan Y, Geng L, Ji Q, Peng Q, Sun S, Wang Y, Xin Z, Yan K, Yang Y, Yu J, Yan H, Ai D, Bai Y, Bi Y, Bian XW, Bu P, Cai JP, Cao CM, Cao F, Cao Z, Chai R, Chan P, Chen C, Chen CS, Chen C, Chen D, Chen HZ, Chen L, Chen Q, Chen X, Chen X, Chen Y, Chen ZJ, Ci W, Dai Z, Ding Q, Dong B, Dong J, Fan JG, Feng S, Feng X, Feng Y, Fu X, Fu X, Gao F, Gao J, Gao Q, Gao S, Gu Y, Guan Y, Guo F, Han JJ, Hao H, Hao J, He F, He J, He M, He M, He Q, He Z, He Z, Hong H, Hong J, Hou S, Hu C, Hu P, Hu Z, Huang C, Huang J, Huang K, Huang P, Ji X, Ji Y, Jia S, Jiang H, Jiang W, Jin L, Jin ZB, Ju S, Ju Z, Kong QP, Kong W, Kong WJ, Kong X, Lei G, Li GL, Li J, Li J, Li M, Li R, Li W, Li W, Li XJ, Li X, Liang Q, Liang Z, Lin H, Liu B, Liu CY, Liu C, Liu F, Liu J, Liu JP, Liu K, Liu L, Liu P, Liu Q, Liu Q, Liu T, Liu W, Liu X, Liu Y, Liu Y, Liu Y, Liu Y, Liu Z, Long X, Lu Y, Luo J, Luo X, Ma C, Ma S, Ma X, Mao J, Mao Z, Ng SC, Nie G, Niu Y, Peng Y, Pu J, Qi J, Qiang L, Qiao J, Qin Y, Qu A, Qu J, Ren J, Ren R, Ruan XZ, Shi A, Shi H, Shi J, So KF, Song M, Song W, Songyang Z, Su J, Sun A, Sun L, Sun Q, Sun YE, Sun Y, Tang P, Tang QQ, Tang … See abstract for full author list ➔ Li J, et al. Among authors: zhang wj. Nat Aging. 2025 Sep;5(9):1669-1685. doi: 10.1038/s43587-025-00935-w. Epub 2025 Sep 9. Nat Aging. 2025. PMID: 40926127 Review.
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: zhang wj. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial.
Li JJ, Wang ZH, Chen L, Zhang WJ, Ma LXX, Wu J, Liu GY, Hou YF, Yu KD, Di GH, Fan L, Jiang YZ, Jiang SH, Liang QN, Shen Y, Shao ZM. Li JJ, et al. Among authors: zhang wj. Ann Oncol. 2025 Jun;36(6):651-659. doi: 10.1016/j.annonc.2025.02.011. Epub 2025 Mar 4. Ann Oncol. 2025. PMID: 40049447 Free article. Clinical Trial.
2,083 results